- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Patent holdings for IPC class A61P 17/02
Total number of patents in this class: 4320
10-year publication summary
161
|
182
|
186
|
285
|
399
|
396
|
427
|
455
|
399
|
93
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Allergan, Inc. | 2600 |
25 |
The Regents of the University of California | 18943 |
24 |
Centre National de La Recherche Scientifique | 9632 |
21 |
Agency for Science, Technology and Research | 3512 |
20 |
KLOX Technologies Inc. | 89 |
18 |
RENOVO Limited | 37 |
16 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
16 |
Daiichi Sankyo Company, Limited | 1829 |
14 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
14 |
The Johns Hopkins University | 5377 |
13 |
Osaka University | 3143 |
13 |
Shionogi & Co., Ltd. | 914 |
13 |
Novartis AG | 11238 |
12 |
Takeda Pharmaceutical Company Limited | 2961 |
12 |
Shiseido Company, Ltd. | 3761 |
12 |
Ethicon, Inc. | 1310 |
11 |
MiMedx Group, Inc. | 207 |
11 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
10 |
Kyowa Hakko Kirin Co., Ltd. | 285 |
10 |
Nippon Shinyaku Co., Ltd. | 297 |
10 |
Other owners | 4025 |